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bicomponent fiber production, self-
assembly, centrifugal spinning, melt 
blowing, and electrospinning.[10–16] While 
all of these approaches have advantages, 
they are not without their limitations. 
Although nanofoams with highly desirable 
structures can be produced using phase 
separation, the process is complicated and 
lengthy. Additionally, while self-assembly 
is capable of producing very fine diameter 
fibers, the productivity level of this method 
is very low.[14] As a result, electrospinning 
is one of the most widespread laboratory 
fiber fabrication techniques and is cer-
tainly one of the most widely reported in 
academic literature.
Electrospinning is largely successful in 
that it affords fibers in the nanometer range 
that can be produced continuously, yet it 
is by no means perfect.[17] It requires high voltages to overcome 
the surface tension of the polymer solution in order to produce 
fibers which it deposits in a whipping motion, leading to random 
alignment due to electrostatic interactions and asymmetric insta-
bilities.[18] Although the commercial viability is limited some-
what due to the emergence of only single fibers from the nozzle, 
polymide nanofibers have been scaled-up for energy storage 
applications.[19,20]
Nozzle-free methods of fiber production have been devel-
oped through centrifugal spinning, a voltage-free technique 
that relies on centrifugal force to produce fine fibers which, 
like electrospinning, has a wide variety of applications—from 
energy storage to tissue engineering.[21–24] Forcespinning, a type 
of centrifugal spinning, can produce nanoscale fibers through 
careful design of geometry and morphology of spinnerets.[25] 
These methods have demonstrated superior fiber yields com-
pared to previous electric field–based methods and variations 
on these have been developed such as liquid shearing spinning, 
brush spinning, and magnetospinning.[26–29]
Established in 2013, pressurized gyration (PG) combines the 
features of solution blowing and centrifugal spinning to pro-
duce large quantities of homogenous fibers with even greater 
control over final product morphology due to the increased 
number of parameters that can be finely tuned.[30] At nearly 5 
years since its inception, this is a timely opportunity to feature 
the research and development conducted using this polymer 
processing method and to analyze its success to date. Here, we 
provide a thorough introduction to PG, detailing all of the pro-
cessing and solution parameters involved. The research to date 
is summarized and an outline of application areas and future 
scope is provided.
Pressurized Gyration
In this invited feature article, the invention of pressurized gyration in 2013 
and its subsequent development into sister processes such as pressurized 
melt gyration, infusion gyration, and pressure-coupled infusion gyration 
is elucidated. The fundamentals of these processes are discussed, eluci-
dating how these novel methods can be used to facilitate mass production 
of polymeric fibers and other morphologies. The effects of the main system 
parameters: rotational speed and gas pressure, are discussed along with 
the influence of solution parameters such as viscosity and polymer chain 
entanglement. The effect of flow of material into the gyrator in infused gyra-
tion is also illustrated. Examples of many polymers that have been subjected 
to these processes are discussed and the applications of resulting products 
are illustrated under several different research themes such as, tissue engi-
neering, drug delivery, diagnostics, hydrogels, filtration, and wound healing.
1. Introduction
To produce functional materials from polymeric fibers, for 
example, biomaterials, forming must take place on a techno-
logically relevant scale, with a high surface area and tunable 
porosity.[1] Materials with these characteristics have been uti-
lized in filtration, medical textiles, biosensing, catalysis, lab-
on-chip technologies, as scaffolds in tissue engineering, and 
as encapsulation materials in therapeutic delivery.[2–7] Still, the 
demand for ultrafine polymeric fibers is on the rise due to their 
inherent versatility.[8] To be valuable in all of these application 
areas, it is critical that fibers can be mass produced in a con-
sistent, reliable, and cost-effective manner.[9]
Nanostructured polymeric materials with the aforemen-
tioned characteristics have been produced via a number of 
methods. These include phase separation, template synthesis, 
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2. Fundamentals of Pressurized Gyration
The laboratory setup of PG (Mark I device) consists of a small 
(35 mm × 60 mm) aluminium cylindrical vessel with multiple, 
narrow (0.5 mm) perforations.[20] The vessel itself is attached 
to an electric motor, capable of rotational speeds of up to 
36 000 rpm. Speed can be easily varied via the use of a con-
troller that adjusts the current to the motor. A gas inlet that 
feeds nitrogen via plastic tubing is fastened to the lid of the 
vessel. The gas pressure can be increased up to 0.3 MPa. A 
pre-prepared polymer solution is loaded into the interior of the 
rotating vessel and the gas inlet is secured in position. The pro-
cess of forming fibers occurs following the combined applica-
tion of the motor and gas pressure. As the vessel rotates, the 
solution is forced out through the perforations and extrudes as 
a polymer jet which dries, leaving behind fibers.[31,32] The appa-
ratus is situated within a chamber in which fibers are depos-
ited and later collected. (Figure 1) summarizes the basic setup.
2.1. Principles of Pressurized Gyration
PG operates through the manipulation of the Rayleigh–
Taylor instability of a chosen polymer solution. Upon starting 
the motor, the rotational speed rapidly increases, leading 
to a greater centrifugal force, causing displacement of the 
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poly mer solution. The applied gas pressure acts against the 
liquid causing a pressure differential in the vessel, forcing the 
solution out. Centrifugal force is the main driver behind liquid 
extrusion through the vessel orifices.[33] A focused polymer jet 
Figure 1. Schematic overview of the fundamental pressurized gyration 
equipment rig.
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is created as a surface tension gradient occurs along the liquid–
air interface.[30] This gradient is also responsible for prompting 
a Marangoni stress tangential to the liquid–gas interface, 
which instigates flow to the tip of the polymer droplet.[34]
Formation of fibers arises when the polymer jet leaving the 
perforations is continually stretched by the centrifugal force and 
the pressure differential created by the gas inlet at the orifices.[35] 
The solvent is gradually lost by evaporation and the extruded 
polymer remaining in the jet is the origin of a fiber strand. The 
dried fiber is eventually deposited on the nearby collection walls; 
the process is rapidly repeated to give rise to a bundle of fibers.
2.2. System Parameters
Fiber formation is highly dependent on the solution properties 
and the processing parameters. Solution properties ultimately 
govern spinnability and can be found to affect fiber forma-
tion just as they would in other methods such as electrospin-
ning.[36,37] The rotational speed of the vessel and the applied gas 
pressure are the two most crucial processing parameters that 
have a marked effect on fiber morphology. Furthermore, varia-
tion of collection distance and environmental conditions alters 
fiber structure.
2.2.1. Rotational Speed
Centrifugal force intensifies with increasing rotational speed; 
therefore, higher rotational speed of the vessel results in 
greater manipulation of the polymer solution. The polymer jet 
is continually stretched and elongated by the centrifugal force 
and the solvent promptly evaporates, presenting fine fibers.
A critical minimum rotational speed must be met for fiber 
formation. Below this, the centrifugal force cannot overcome 
the surface tension and there is no polymer jet. At low rota-
tional speeds and as the vessel is accelerating, the solvent may 
separate from the polymer due to its lower surface tension. Typ-
ically, a polymer jet does not form in this scenario and solvent 
is lost to the surrounding collection walls. As such, a suitable 
rotational speed is essential for the production of a polymer jet 
and subsequent fiber formation.
The solution properties, mainly surface tension, influence 
the minimum critical rotational speed. Beyond the threshold 
speed, subsequent increases in rotational speeds will cause 
even greater stretching and thinning of the polymer jet. Rapid 
solvent evaporation occurs as the surface area is increased and 
this results in smaller diameter fibers (Figure 2). The implica-
tions of even higher rotational speeds on polymer jet stability 
are yet to be explored.
2.2.2. Gas Pressure
For optimal fiber yield and morphology, gas pressure must 
be applied after reaching critical rotational speed. During 
the initial acceleration phase of the motor, critical rotational 
speed is not met and the application of gas pressure causes 
loss of solvent through the orifices, as the solvent has a lower 
surface tension than the polymer. This is because, the gas 
pressure acts as the driving force and the solution is expelled 
through the vessel apertures whilst having insufficient pres-
sure differential to overcome the surface tension to form a 
polymer jet. The higher the gas pressure the greater the loss 
of solvent.
Fiber morphology is directly influenced by applied gas 
pressure. A pressure differential within the vessel causes 
acceleration of the solution through the orifices.[38] The gas 
pressure contributes to additional polymer jet elongation by 
way of fluid acceleration and increased kinetic energy of the 
emerging jet. Jet elongation yields lower diameter fibers as 
the polymer jet lengthens, leading to rapid solvent evapora-
tion.[39] Although a maximum of 0.3 MPa applied pressure is 
generally used, the effects of even higher pressures are yet to 
be investigated.
Surface topography of the formed fibers can be altered by 
varying gas pressure. When highly volatile solvents are used, 
this causes a local temperature drop and surface pores result 
due to water droplet evaporation from the fiber surface.[40] At 
higher applied working pressures, the temperature drop is 
greater, leading to more rapid solvent evaporation and pore 
formation.
2.2.3. Collection Setup
Manipulation of collection distance gives rise to bead-on-string 
morphology, which can be advantageous in producing superhy-
drophobic fibers with good mechanical integrity—both excel-
lent properties for air filtration applications.[41,42] The formation 
of bead-on-string fibers can be controlled by solution molecular 
weight and concentration.[43] At shorter collection distances, sol-
vent evaporation is reduced and solvent droplets remain on the 
fiber chain. These unevaporated droplets prevent proper mixing 
of the polymer within the drying jet, creating beaded fibers.
Fiber diameter is reduced by increased collection dis-
tances. The jet is allowed to stretch further at higher distances, 
leading to narrower fibers (Figure 2). Jet thinning coupled with 
increased solvent evaporation leads to thinner fibers on the col-
lector. With insufficient collection distance the motion of the jet 
is obstructed and fiber morphology is altered.
Macromol. Mater. Eng. 2018, 1800218
Figure 2. Diagrammatic representation of the pressurized gyration 
spinning process demonstrating the effect of centrifugal force on the 
polymer jet.
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Various modifications to the collectors have been used to 
influence fiber morphology and deposition. By incorporating a 
collector similar to that in Figure 3, uniaxially aligned fibers can 
be achieved. The collection setup increases fiber alignment due 
to the placement of protruding rods oriented around the pot.
2.3. Infusion Gyration
Infusion gyration is a novel technique based on PG that allows 
for the regulation of solution flow rate, which can directly influ-
ence yield, fiber size, distribution, and morphology. This setup 
overcomes the limitations in the lack of control over the flow 
dynamics of the polymer solution from the Mark I device. The 
setup comprises an aluminium cylindrical vessel with 20 small 
perforations on its face. The bottom of the vessel is fastened to 
a high-speed motor which allows the vessel to rotate at speeds 
of up to 36 000 rpm. The gas pressure inlet is replaced with an 
inlet joined to a syringe pump, allowing for solution flow-rate 
control.
Infusion gyration is dependent on the polymer infusion rate 
rather than the gas flow. The precise control over the flow rate 
allows for the fabrication of well-aligned, smooth, and bead-
free nanofibers.[44] At higher flow rates, there is an increase 
in hydrostatic pressure. At the orifice, the hydrostatic pres-
sure is lower than the centrifugal force and thus the final 
fiber size and distribution is determined by the destabilizing 
centrifugal force and the surface tension of the polymer solu-
tion.[45] Fiber diameter rises with increasing flow rate as there 
is a higher volume of polymer and greater mass transfer at the 
orifice. For example at 500 µL min−1, the mean fiber diameter 
is 117 nm whereas at 2000 µL min−1, the mean fiber diameter 
is 170 nm. When solvent evaporation and mass transfer are in 
equilibrium, low diameter fibers can be achieved. The shape 
and volume of the emerging polymer droplets can be altered 
by varying flow rates, having a marked effect on fiber size and 
distribution. At higher infusion rates, the production rate is 
generally greater due to the increased volume of material in 
the rotating vessel.
2.4. Pressure-Coupled Infusion Gyration
Fiber formation using pressure-coupled infusion gyration 
(PCIG) is governed by centrifugal force, dynamic fluid flow, and 
applied gas pressure.[46] In this system, the rotating aluminium 
vessel is connected to the gas inlet through an acrylic T-junction, 
while polymer solution is infused by a syringe pump. Variation 
of infusion rate allows for manipulation of the fiber diameter. 
Stretching of the polymer jet is enhanced at higher rotational 
speeds and centrifugal force. Solution blowing as a result of gas 
pressure causes further acceleration and manipulation of the 
polymer jet. PCIG allows for additional processing parameters 
to be considered for further tailoring of the final product mor-
phology. It also allows polymers that are otherwise poorly spin-
nable to be processed into fibrous products.[47] For optimization 
of the system parameters, modeling of PCIG using response 
surface methodology is in progress. First results have shown 
that polymer concentration in solution and gas pressure may 
have a more significant effect on fiber morphology than previ-
ously known.[48]
2.5. Pressurized Melt Gyration
Pressurized melt gyration is a process of forming fibers that 
does not require the use of solvents. The absence of solvents 
unwraps potential in a variety of applications where cytotox-
icity is a concern.[49] As with conventional gyration, pressur-
ized melt gyration utilizes the identical apparatus setup but 
also incorporates a heating gun.[50] The temperature of the pot 
can be directly regulated and controlled by the heat gun, which 
is capable of producing temperatures of up to 400 °C. The 
high temperatures experienced in the gyration vessel induce a 
polymer melt, which undergoes the same forces at the vessel 
orifices as a polymer solution would.
Increased pot temperature reduces fiber diameter. At higher 
temperatures, the molten polymer remains in a liquid state for 
a longer duration, permitting a greater extent of jet stretching. 
As the molten polymer jet escapes from the orifices, exposure 
to the open environment causes rapid cooling and fibers are 
formed as a result of jet cooling and thinning. Furthermore, 
the viscosity of the melt reduces with increasing temperatures, 
which also attributes to the reduction in fiber diameter.[51] Low 
viscosity instigates additional stretching of the emerging jet 
and leads to the production of thinner fibers.
Figure 3. Collection setup that has produced highly aligned fibers.
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3. Properties of Materials
3.1. Solution Spinnability of Polymers
To date, many different polymers have been successfully spun 
into fibers using PG and it has been found that a variety of 
solvents can be combined to dissolve the same polymer. Diam-
eters as low as 60 nm have been achieved. Unlike electrospin-
ning and other fiber production methods, PG alleviates the 
need for an applied voltage, so the electrical properties of the 
spinning solution need not be considered.[52] Note that loading 
the solution into the vessel is slow and solvent evaporation can 
be an issue. As previously described, this can be avoided if an 
infusion method is used and the environment is controlled. 
Table 1 shows the polymers that have been spun along with 
their concentration, molecular weight, and the solvent used. 
The potential applications of the fibers produced are given.
3.2. Mapping Solubility and Spinnability
Solvents must be carefully selected to ensure fibers can be pro-
duced in polymer–solvent systems. Solution parameters such 
as viscosity and molecular weight significantly affect the fiber 
outcome, so the appropriate criterion to produce fibers for a 
particular polymer must be confirmed. Moreover, the solvent 
will determine the critical minimum polymer concentration 
and chain entanglement, which must be optimized to yield 
fibers (rather than other morphologies, i.e., beads).
The spinnability of polyethylene terephthalate (PET) has 
been investigated. To determine whether a solvent with a high 
solubility for PET would yield fibers, a wide variety of solvents 
and solvent systems with varying solubility parameters were 
mapped onto a Teas graph. The solubility–spinnability region 
in various solvent systems was determined based on the time 
taken for it to dissolve in each system to form a homogenous 
solution.[33] By combining solubility and spinnability, a solvent 
with high solubility for PET (trifluoracetic acid) was found to 
produce nanofibers (Figure 4). Solvents with low solubility 
(formic acid and dichloromethane) were found to produce 
beads from the same concentration of solution (20 wt%).
A Teas graph was also used to help select a binary solvent 
system. A solvent with high solubility for PET, trifluoroacetic 
acid (TFA), and a non-solvent were used. Assuming that the 
combined solvents would have the same solubility parameters 
as those solvents with high solubility for PET, the solvent ratios 
were determined. For TFA + dichloromethane (DCM) a ratio 
of 1:1 was observed. For TFA + DMF and TFA + chloroform 
(CHCl3) the ratio was 4:1. The parameters for the solvent TFA 
and DCM (1:1) were very close to those of TFA, which is known 
to dissolve PET and therefore the binary solvent system was 
expected to produce fibers.
Scaling laws were determined for the relationship between 
polymer concentration and viscosity using the solvents deemed 
appropriate from the Teas graph. Plots of specific viscosity 
against PET concentration revealed that increasing the weight 
percentage increased the specific viscosities. The scaling 
values were found to be in good agreement for the theoretical 
predictions for entangled solutions in a good solvent. The 
results demonstrated that there needs to be a minimum pol-
ymer concentration Ce for nanofiber generation, and therefore 
there must also be a minimum level of chain entanglement. 
Below Ce only beads are observed but, it should be noted, that 
the minimum polymer concentration will be different for dif-
ferent polymers, molecular weights, and solvent systems. PG 
allows for tailoring of the microstructural evolution so that 
beaded products can be generated.[38]
Following this, a mathematical model using rotational and 
blowing frames was developed and adapted from Mellado 
et al.[45] to elucidate a relationship between fiber diameter and 
experimental parameters such as fiber velocity, air velocity, 
kinematic viscosity, angular velocity of the vessel and the col-
lector to vessel radius. r1 is the initial jet radius, r2 is the final jet 
radius, v
u
p=  is the kinematic viscosity, Rc is the radius of the 
collector, U is the initial velocity and Ω is the angular velocity. 
Va is the air velocity [Equation (1)].
r
rU v
R V
2
1
3/2 1/2
c
3/2
a
=
Ω
 (1)
The final fiber radius results from competing surface ten-
sion, viscosity, rotation speed, and air velocity. In this first 
model for the PG process, only rotation speed, viscosity, and 
air velocity were varied to determine the effect on fiber diam-
eter. This work shows the importance of mapping solvent–
spinnability for a particular polymer solvent system. Using a 
Teas graph, polymer fibers can be designed through their sol-
vent interactions prior to spinning using PG but ultimately, a 
greater understanding of the physical properties of the polymer 
solutions is needed to refine Equation (1), to predict r2 and thus 
the final fiber diameter.
3.3. Properties of Fibers
Much like electrospinning, the ultimate processing goal is 
to maintain consistent fiber diameters at long lengths with 
controllable surface morphology. When these conditions are 
achieved PG will be scaled-up for manufacturing. Table 2 
reports the effect of varying PG parameters and their contribu-
tion to the aforementioned requirements. Currently PG is able 
to achieve such targets only with respect to certain polymers, for 
example poly(ethylene oxide) and polycaprolactone. Thus, more 
modeling-based research is necessary to elucidate the effect of 
these parameters on the outcome of different polymers.
4. Applications
4.1. Drug Delivery
In recent years, micro- and nanoscaled fibers have been increas-
ingly used as drug-delivery vehicles.[64–66] Poor solubility of 
countless drugs can be overcome by dispersing the drug mol-
ecules within polymer solutions, which are then spun as fibers. 
PG and its sister processes provide an attractive manufacturing 
route for low diameter fibers, which have shown great potential 
Macromol. Mater. Eng. 2018, 1800218
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Table 1. Polymers spun in solution using pressurized gyration with or without modification.
Polymer Solvent
Details (molecular weight or details 
of each polymer in copolymer/
composite/blend) Concentrations spun
Product charac-
teristics [unless 
otherwise 
stated, fiber 
diameter in nm] Application Reference
Polyethylene oxide 
(PEO)
Distilled water Mw 200 000 g mol−1 5, 15, 21 wt% 60–1000 Aligned polymeric 
nanofibers
[30]
PEO, polyacrylic acid 
(PAA), sodium 
carboxymethylcellu-
lose (CMC), sodium 
alginate
Distilled water Mw CMC = approx. 250 000 g mol−1
Mw PEO = approx. 200 000 g mol−1
Mw PAA = 450 000 g mol−1
Sodium alginate = medium 
viscosity
15 wt% PEO/PAA 4.5 wt%
5 wt% PEO/CMC 4.5 wt%
15 wt% PEO/alginate 4.5 wt%
161–280 Vaginal drug 
delivery
[53]
Potato starch 
((C6H10O5)n, 
amylose:amylopectin 
25:75): PEO
Distilled water, 
dimethyl sulf-
oxide (DMSO) 
(50:50)
Mw PEO = 200 000 g mol−1
Mw starch = approx. 106 g mol−1
PEO:Starch:
13.5:1.5 wt% (90:10)
11.5:4.5 wt% (70:30)
7.5:7.5 wt% (50:50)
160–650 Scaffolds for tissue 
engineering, 
protein drug 
release
[20]
PEO and DsRed-
AuBP2-engineered 
protein
Distilled water Infusion Gyration:
Mw PEO: 200 000 g mol−1
DsRed-AuBP2-engineered protein: 
30 kDa
5, 10, 15, 21 wt% 117–216 Biohybrid mate-
rials for imaging, 
sensing, and 
biomaterials
[44]
Poly-N-vinylpyrrolidone 
(PVP): Kollidon 25 
(K25), Kollidon 30 
(K30), and Kollidon 
90F binder (K90F)
Phosphate-
buffered saline 
(PBS) solution 
prepared using 
distilled water
Mw K25 = 28 000–34 000 g mol−1
Mw K30 = 44 000–54 000 g mol−1
Mw K90F = 1 000 000–1 500 000 g 
mol−1
10, 20, 30% w/v (repeated for each 
binder)
462–971 Nanofiber meshes [39]
Ibuprofen 25 (BCS 
II) (IBU) in PVP 
(Kollidon 90F)
Ethanol Mw IBU = 206.28 g mol−1
Mw K90F = 100 000−150 000 g 
mol−1
K90F concentration was fixed at 
10% w/v, IBU concentration was 
adjusted to 10, 30, and 50%:
IBU-K90F 10%, IBU-K90F 30%
IBU-K90F 50%
1500–1900 Drug-loaded nano-
fibers for oral 
administration
[54]
Polyethylene (tere-
phthalate) (PET)
Trifluoroacetic acid, 
trichloroacetic 
acid, dichlo-
romethane, 
chloroform, 
dimethyform-
aldehyde (all in 
various mixtures)
Mw PET = 100 000 g mol−1 5, 10, 15, 20, 25 wt% 290–675 Potential use in 
filters
[33]
Nylon 6,6 modified 
with functional Ag 
nanoparticles (NPs).
Formic acid 
(aqueous Ag 
NPs)
Mw nylon 6,6 = 30 000 g mol−1
Particle size Ag NPs = 150 nm
Nylon + Ag:
5 + 0 wt%
10 + 0 wt%
15 + 0 wt%
20 + 0 wt%
5 + 1 wt%
10 + 1 wt%
15 + 1 wt%
20 + 1 wt%
Nylon: 59–470
Nylon + Ag: 
57–152
Antibacterial fiber 
mats
[55]
Poly(vinyl alcohol) 
(PVA), lysozyme 
from chicken egg 
white, Au NPs
PBS, distilled water Mw PVA = 146−186 kDa, 87−89% 
hydrolyzed
Mw lysozyme = 14.3 kDa, ≈70 000 
U mg−1
Average diameter Au NPs ≈10 nm
Au nanoparticle solution and PVA-
lysozyme solution with v/v ratios of 
1:10, 1:5, and 2:5 were used to pre-
pare gold-nanoparticle-encapsulated 
microbubbles.
Bubble 
diameter = 
50–450 µm
Antibacterial 
microbubbles 
with biosensing 
capabilities
[56]
PCL, Silver (Ag) NPs Triethylene glycol 
monomethyl 
ether for Ag NP 
suspension
Pressurized melt gyration:
Mn PCL ≈ 80 000
Particle size Ag NPs = 10–150 nm
PCL-95 °C, PCL-105 °C, 
PCL-125 °C, PCL-150 °C,  
PCL-155 °C, PCL-200 °C
PCL-Ag 95 °C, PCL-Ag 125 °C, PCL-Ag 
155 °C, PCL-Ag 200 °C
Ag NP solution: 0.01% v/v
14–38 µm Antibacterial mats, 
wound healing
[50]
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Polymer Solvent
Details (molecular weight or details 
of each polymer in copolymer/
composite/blend) Concentrations spun
Product charac-
teristics [unless 
otherwise 
stated, fiber 
diameter in nm] Application Reference
Graphene–SiOC/PVP n Chloroform and 
dimethylfor-
mamide (DMF) 
binary  
solvent
(B1) Polymethyl-silsesquioxane 
(MK) resin solution (Mw =  
9100 g mol−1)
(B2) Polymethylphenyl-silsesqui-
oxane (H44) resin solution (Mw = 
2100 g mol−1)
(B3) H44 + 3% graphene solution
Mw PVP ≈1 300 000 Da
(Sn containing dibutyltindilaurate 
and Zr-acetylacetonate were used 
as catalysts for MK and H44 
resins, respectively)
(B1) MK/PVP: 25 wt% resin
(B2) H44/PVP: 20.7 wt% resin
(B3) H44/ PVP/graphene: 20.7 
wt% resin
1000–5000 Industrial ceramics [57]
Polyacrylonitrile (PAN), 
polymethylmethacry-
late (PMMA)
DMF Mw PAN = 150 000 g mol−1
Mw PMMA = 120 000 g mol−1
S1 PAN: 4% w/v
S2 PAN: 8% w/v
S3 PAN:10% w/v
S4 PMMA: 30% w/v
S5 50:50 PAN–PMMA (20% w/v total 
polymer)
290–580 Porous nanofibers [58]
PCL Acetone Mw PCL = 80 000 5, 10, 15, 20, 25, and 30 wt% ≈351 µm Beads on a string 
for drug carrying
[38]
Graphene nanoplate-
lets (GNPs) loaded 
thermoplastic poly-
urethane (TPU) and 
phenolic resin (PR)
DMF TPU, Desmopan DP 9855DU
PR, (Bayer, Italy)
GNPs ≈ 964 × 457 nm (L × W)
Mw PVP ≈1 300 000 Da
15% TPU-5%GNP
20% TPU-5%GNP
25% TPU-5%GNP
10% PR-10%PVP
15% PR-10%PVP
20% PR-10%PVP
10% PR-10%PVP-5%GNP
15% PR-10%PVP-5%GNP
20% PR-10%PVP-5%GNP 0.75
1000–9000 Graphene 
reinforced 
composites
[59]
PAN-based graphene 
nanoplatelet loaded 
fibers
DMF Mw PAN = 150 000 g mol−1
GNPs: ≈2 nm, diameter of 1−2 µm, 
average surface area of ≈750 
m2g−1, and bulk density of ≈0.2 g 
cm−3
GNPs (0, 0.2, 1.0, 3.0, and 8.0 wt%) 
dispersed in PAN solution (10 wt% 
PAN in DMF)
1000–5000 Carbon nanofibers [60]
PAN, cellulose acetate 
(CA), and (PAN-CA)
DMF, acetone Mw PAN = 150 kDa
Mw CA = 30 kDa
PAN solutions (5, 10, 15 wt%)
CA solutions (15, 20, 25 wt%)
10 wt% PAN-CA
200–2000 Porous struc-
tures for 
electrochemistry
[61]
Antimicrobial nanopar-
ticle (AMNP) loaded 
PMMA fibers
Chloroform Mw PMMA = 120 000 g mol−1
Antimicrobial nanoparticles (two 
types: AMNP1 and AMNP2) 
(University of Hertfordshire)
K0 20% w/w PMMA
K1 0.1% AMNP1 loaded w/w PMMA
K2 0.25% AMNP1 loaded w/w PMMA
K3 0.5% AMNP1 loaded w/w PMMA
K4 0.1% AMNP2 loaded w/w PMMA
K5 0.25% AMNP2 loaded w/w PMMA
K6 0.5% AMNP2 loaded w/w PMMA
6–20 µm Antimicrobial 
filters
[62]
Poly(L-lactide)/
poly(methyl 
methacrylate) 
(PLLA)/PMMA + 
hydroxyapatite (HA) 
nanopowder
Chloroform PLLA (amine-terminated, average 
Mn 2500, polydispersity ≤ 1.3), 
PMMA (average Mn 1 20 000)
HA particle size ≤ 200 nm
PLLA/PMMA 50:50, 20 wt% ≈17 µm Mechanically 
active bone 
tissue scaffolds
[63]
PEO Water Pressure-Coupled Infusion Gyration
PEO, Mw 200 000
(3, 5, 10, 15, and 21 wt%) 100–2400 Oriented polymeric 
fiber mats
[46]
Table 1. (Continued).
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in drug delivery. In fact, recently prepared polymer-magnetic 
composite fibers fabricated by infusion gyration have been suc-
cessful in remote-controlled drug release.[67]
Drugs in crystalline form possess strong intermolecular 
bonds that require a higher energy barrier to dissolution, 
leading to lower solubility.[68] By solubilizing a drug with a suit-
able solvent, it is converted into its amorphous form and the 
energy barrier to dissolution is lowered.[69] The amorphous 
solution can then be mixed with a hydrophilic polymer solu-
tion and processed into fibers using PG. The resulting fibers 
hold the amorphous drug molecules via steric hindrance of the 
polymer chains. As the hydrophilic polymer dissolves, drug 
molecules are released as fine colloidal particles.[70] The high 
surface area to volume ratio of these fibers further enhances 
drug dissolution due to the increased contact area to the 
dissolution media.[71] PG overcomes a significant limitation in 
the large-scale manufacture of micro- and nanofibrous drug 
systems, allowing for production rates in excess of kilograms 
per hour.[39]
PG was used to prepare fibers with varying percentage load-
ings of ibuprofen dispersed in polyvinylpyrrolidone (PVP).[54] 
Dispersions of ibuprofen demonstrated a significant increase 
in drug-release rate when compared to the drug powder. As 
drug content increased, solution viscosity, and surface tension 
increased. Such qualities have a marked effect on bead size, 
fiber diameter, and even jet stability, yet drug-loaded fibers 
did not differ in surface topography compared to unloaded 
fibers.[20,72–74] Drug content increased as fiber diameter 
increased, concurrent with literature values.[66,75] X-ray diffrac-
tion patterns confirmed the presence of amorphous drug within 
the fibers, explaining increased solubility. Fourier transform 
infrared spectroscopy (FTIR) data evidenced strong drug–
polymer hydrogen bonding. Rapid solvent evaporation during 
the PG process allowed for the production of fibers with com-
plete drug–polymer miscibility. This was confirmed by modu-
lated temperature differential scanning calorimetry (DSC), 
where a single glass transition temperature (Tg) was detected.
PG has been used to prepare nanofibers with mucoadhesive 
properties for use in vaginal therapy.[53] Drug delivery to the 
mucosal sites of the body is advantageous as it improves patient 
compliance and topical targeting. Nanofibers are valuable in 
topical and mucosal drug delivery due to their high surface 
area to volume ratio, enabling delivery across the mucosal bar-
riers—where highly bulky and hydrophilic peptide and protein 
drugs would otherwise have difficulty.[76] Two highly mucoad-
hesive polymers, carboxymethyl cellulose and polyacrylic acid, 
were prepared as blends using PEO as a carrier, yielding well-
defined and uniformly cylindrical fibers with high structural 
integrity. FTIR data established the presence of mucoadhesive 
properties. Atomic force microscopy was used to further con-
firm mucoadhesive properties of the fibers with simulated vag-
inal mucin, demonstrating significant potential of the fibers for 
use in vaginal therapy.[77]
In a separate but related study, PG was used to develop 
progesterone-loaded bioadhesive nanofibers as a drug-delivery 
system for reduced incidence of preterm birth.[78] Polyethylene 
oxide and carboxymethyl cellulose were chosen as carrier poly-
mers due to their mucoadhesive properties. Hot-stage micros-
copy was used to confirm the presence of progesterone within 
the polymeric fibers. Depending on the polymer compositions, 
the resulting fiber diameters ranged from 40 to 1000 nm. 
A high (25 wt%) loading of progesterone was achieved. The 
nanofibers indicated a higher and more uniform drug-release 
when compared to a commercially available progesterone pes-
sary (Cyclogest). Nanofibers produced using PG have enabled 
the delivery of progesterone to the vaginal mucosal membrane 
where incorporation of poorly water-soluble drugs into hydro-
philic nanofiber carriers is particularly challenging.
Fibers produced by PG demonstrated more rapid drug release 
compared to those produced using electrospinning. Ampho-
tericin B and itraconazole, two poorly water-soluble drugs, were 
dispersed within polymeric fibers produced using both electro-
spinning and PG. The morphology of the fibers constructed by 
Figure 4. Teas graph showing solubility–spinnability map of PET. Circled 
region shows the selection of a binary solvent system. Adapted with per-
mission under the terms of the CC BY 4.0 license.[33] Copyright 2015, The 
Authors. Published by Elsevier B.V.
Table 2. Effect of pressurized gyration parameters on fiber diameter 
and/or fiber surface.
Parameter Fiber properties
Process parameters ↑ Working pressure ↓ Fiber diameter
↑ Rotational speed ↓ Fiber diameter
Solution parameters ↑ Polymer molecular 
weight
↑ Fiber diameter
↑ Polymer concentration 
(viscosity)
↑ Fiber diameter
↑ Solvent volatility ↓ Fiber diameter
↑ Pore size on fiber surface as 
evaporation increases
System parameters ↑ Orifice size ↑ Fiber diameter
Ambient ↑ Temperature No effect unless temperature is 
increased much higher as with 
pressurized melt gyration
↑ Relative Humidity ↓ Uniformity
↑ and ↓ denote increase and decrease respectively. It should be noted that these 
are the most common overall outcomes and exceptions may exist for some pol-
ymer systems and polymer concentrations used.
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the two techniques differed (Figure 5), which may explain the 
differences in their drug release profiles.[79] Previously, incor-
poration of uniformly dispersed drugs into electrospun fibers 
was hindered by the low yield of the method.[9] PG allows for 
significant fiber production rates in a single step and has the 
potential to be scaled further.
4.2. Tissue Engineering
Polymer nanofibers have shown significant promise in tissue 
engineering applications.[80] The high surface area to volume 
ratio provides ideal conditions for the formation of an extracel-
lular matrix (ECM) to match that of native tissue.[81] Not only 
this, the aligned fibers offer directionality to cell growth and can 
enhance the deposition of cells and the attraction of ECM fac-
tors such as collagen and elastin.[82] Conventional PG relies on 
the use of solvents which is a potential drawback in the creation 
of tissue engineered constructs. Melt-spinning with regulated 
temperatures allows for good control over surface roughness, 
an essential property that influences cellular infiltration.
In the first study of its kind, a pressurized melt gyration 
process was developed to evade the use of cytotoxic solvents in 
polymer solutions. A heat gun was used in conjunction with 
PG apparatus and applied to the rotating vessel to produce non-
woven PCL and Ag-loaded PCL-based fiber scaffolds with anti-
bacterial properties.[50] Xu et al. obtained PCL scaffolds at melt 
temperatures of 95, 125, 155, and 200 °C at varying working 
pressures and rotating speeds. To evaluate the antibacterial 
activity, Ag-loaded PCL fibers were produced using Ag coated 
pellets that were melt-spun at different temperatures using 
gyration at a speed of 36 000 rpm and 0.01 w/v NP solution.[50]
Fiber diameter was found to be related to melt temperature. 
As the temperature increased, fiber diameter reduced. For the 
PCL molten polymer, increasing the temperature from 95 to 
200 °C reduced the fiber diameter from 38 to 28 µm. Increased 
rotational speed further decreased the fiber diameter to 18 µm. 
As the temperature was increased from 105 to 200 °C and the 
working pressure was increased from 0.1 to 0.2 MPa, the fiber 
diameter was reduced to 15 µm. The effects of working pres-
sure and speed are therefore consistent with what is expected 
for PG. When temperature is increased, the molten liquid 
jet remains in a liquid state for longer, causing additional 
stretching of the polymer fiber jet. Rapid cooling occurs at the 
orifice. The polymer melt viscosity is also reduced at higher 
temperatures, so thinner fibers are achieved with increased 
stretching time and lowered melt viscosity.
The melt temperature of PCL was also found to directly influ-
ence the surface morphology of the scaffolds. Xu et al. found 
that above 105 °C, surface roughness was observed and at 155 
and 200 °C, extrusion lines were visible on the surface of the 
fibers, as well as fibril lines and pits.[50] Raman spectra of the 
PCL scaffolds were used to confirm an increase in crystallinity 
associated with increase in temperature. For the Ag-coated PCL 
scaffolds, no significant difference in molecular structure was 
observed following Raman spectroscopy, although microanal-
ysis in the wavelength 1700–1760 cm−1 showed differences in 
crystallinity, indicating that nanoparticle incorporation prevents 
the movement of molecular chains and thus decreases the 
crystallinity.
Antibacterial activity was significantly higher for the Ag-
coated PCL scaffolds than the PCL control when evaluated 
using both Escherichia coli and Pseudomonas aeruginosa. Melt-
spun scaffolds also proved to be biocompatible with no signs of 
toxicity to the C2C12 cell line and percentage cell proliferation 
was found to be highest at 95 °C. DAPI (4',6-diamidino-2-phe-
nylindole) staining was used to confirm that there was a high 
amount of cell attachment and cell spreading at this tempera-
ture compared to others. Cellular infiltration was found to be 
highest at 155 °C, where the scaffold porosity was large enough 
to allow cells to move inside the scaffolds. This research shows 
the potential of pressurized melt gyration in the production of 
biocompatible fiber mats and the possibilities of using melt 
temperature to control the morphology and topography of 
fibers.
4.3. Diagnostics
The application of nanofibers to the development of biosensors 
and medical diagnostic devices has seen intense interest.[83–85] 
Biosensors encompass a wide range of devices that are used in 
the detection of various analytes. The versatility of nanofibers 
Macromol. Mater. Eng. 2018, 1800218
Figure 5. Scanning electron microscopy images of a) pressurized gyra-
tion drug-loaded fibers possessing a uniaxially aligned profile and b) elec-
trospun drug-loaded fibers showing an overlapping profile.
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in terms of high surface area, porosity, surface architecture, 
and topography provide great practicality and potential as bio-
sensing membranes.[86]
PG allows for the generation of particles and bubbles in 
addition to fibers. Microbubbles can be achieved at a higher 
production rate than those produced using microfluidics or 
sonication. Bubbles are formed as the polymer solution-filled 
vessel rotates. With simultaneous application of gas pressure 
and pot rotation, the external forces combine to create an 
intense vortex leading to deformation of the polymer surface. 
As the rotational speed increases, air penetrates through the 
core of the emerging jet, causing it to shrink and move from 
a stable to an unstable state, producing microbubbles.[35] Rapid 
central rotation of the vessel funnels the flow around the apex 
of the vortex and is followed by a pinching-off process, leading 
to bubble formation.
Protein-coated microbubbles can be made using PG to 
enhance their stability for use in a wide range of biomed-
ical applications—ranging from medical imaging to drug 
delivery.[87–89] A reduction in average microbubble diameter is 
generally observed with increasing rotational speeds above the 
critical minimum speed. The nanoparticle content of the solu-
tion can also affect the diameter and size distribution of the 
bubbles produced. A dramatic reduction in microbubble diam-
eter is observed with increasing applied gas pressure. Although 
PG offers a high-volume production route, monodisperse 
microbubble production for use in biomedical engineering has 
not yet been achieved and more research is needed in this area.
4.4. Hydrogels
Swelling to hold vast amounts of water, hydrogels are cross-
linked hydrophilic polymer networks that are resistant to 
dissolution.[90] Their responsiveness to a number of environ-
mental stimulants makes them effective in various biomedical 
settings.[91,92] Cross-linking allows for superior control over 
physical properties such as viscosity and solubility, forming 
3D insoluble networks from which bioactive molecules can be 
released.[93] Physical cross-linking allows for the formation of 
reversible hydrogels, although this can lead to network defects. 
Permanent or chemical cross-linking, can be achieved through 
covalent bonding.
Common methods for chemical cross-linking often result in 
weak and brittle hydrogels, which are therefore limited in their 
application.[94] As crosslinking is unable to occur at regularly 
separated positions, there is a broad distribution in the length 
of the chains between cross-linking points. Not only this, the 
cross-linking density and inter-crosslinking molecular weight 
cannot be controlled separately. When the concentration of the 
cross-linker is high, heterogeneous aggregation of the cross-
linking points occurs.[95] Hydrogels that have been chemically 
cross-linked are thus limited in terms of their morphology, 
mechanical strength, and optical transparency.[96] Although 
ultra-stretchable, self-healing, and tough hydrogels can be syn-
thesized through physically cross-linking, for example, from 
polyacrylamide-montmorillonite (PAM-MMT), it is difficult 
to achieve low hysteresis, and therefore optimum mechanical 
properties, as some of the organic–inorganic cross-links will 
break. Much research is therefore focused on improving the 
properties of chemically cross-linked hydrogels.
Our laboratory, in association with Chen and coworkers, 
used PG to fabricate PAM-clay nanocomposite hydrogel fibers, 
exhibiting low hysteresis.[95] To do this, in situ polymerization 
of acrylamide (AM) in the presence of MMT or chitosan−
treated MMT (CHI−MMT) was conducted at 60 °C, instead of 
with a catalyst, to allow for chain grafting and branching. The 
radical initiator attacked the hydroxyl groups of the polysaccha-
ride chains to generate alkoxy radicals, initiating polymerization 
of AM. No chemical cross-linker was used and the mechanical 
properties of the nanocomposite hydrogels, prior to swelling 
and when fully swollen, were measured.
PAM-MMT and PAM/CHI−MMT (with chitosan) hydrogel 
fibers were fabricated from precursor materials: water, MMT, 
chitosan, initiator, and monomer. It was found that both hydro-
gels had high strain and that treating with chitosan improved 
physical properties due to electrostatic interactions. Further-
more, both hydrogels in this work demonstrated resilience due 
to strong interactions within the hydrogels as a result of chain 
branching, multiple hydrogen bonding, covalent bonding, and/
or electrostatic force. The exceptional hysteresis results, high 
strength, and resilience of the nanocomposite hydrogels can be 
applied to fiber production using the PG method, having poten-
tial application in many biomaterials areas, due to their ease of 
processing.
4.5. Filtration
Owing to their high surface area to volume ratio and enhanced 
porosity, fibers produced using PG are excellent materials for 
filtration.[97] Application of fibers in filters can be divided into 
liquid and air filtration systems.[98] Polymeric sub-micron-sized 
fibers are used mostly in porous membranes for ultrafiltration 
(excluding particle sizes of 100 nm upward) or nanofiltration 
(excluding particle sizes that are just a few nanometers). Mostly 
these are carbon-based filters that can be used for removing 
contaminants from wastewater, such as phenols, or for the 
purification of drinking water and removal of pesticides.[99–101] 
Air filtration applications include dust collectors and protective 
clothing and importantly, antibacterial hospital filter systems, 
which are becoming increasingly used in the fight against anti-
bacterial resistance.[102]
As infectious diseases and antibiotic resistance become 
increasingly prevalent, there is greater focus on ultrafiltration 
with the incorporation of nanoparticles.[103,104] To produce anti-
microbial ultrafiltration systems for air, tellurium (Te) nanopar-
ticles were embedded into a PMMA mesh using PG.[105] Porous 
PMMA fibers with 1, 2, and 4 wt% Te particles were prepared, 
and SEM was used to confirm dispersion of antimicrobial Te 
particles. Increased concentration of Te particles led to wider 
diameter fibers, from 0% loaded Te fibers having diameters 
of 7.06 ± 3.77 µm to 4% loaded Te fibers having diameters of 
13.9 ± 7.05 µm. Pore size was found to decrease with increased 
fiber diameters and increased Te loading. Te/PMMA fiber 
meshes exhibited antibacterial activity toward Gram-negative 
E. coli, a common cause of hospital acquired infection. The 
bactericidal activity of Te/PMMA fibers was dose-dependent 
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and increased as the percentage loading of Te increased. These 
findings demonstrate the feasibility of Te as an alternative to 
silver nanoparticles, a well-established antibacterial agent.[106] 
In fact, PG is a powerful method by which novel antimicrobial 
agents can be incorporated in polymeric mesh-like filters and 
bandages.[107]
4.6. Wound Healing
PG offers an amenable approach to the mass production of fiber 
mats. Bacterial cellulose (BC), a notoriously difficult polymer to 
process, has been blended with PMMA, to produce BC:PMMA 
bandage-like scaffolds.[108] BC possesses exceptionally high 
water-holding ability, a fine microfibril network and enhanced 
cell compatibility, making it a highly suitable material for use 
in wound healing (Figure 6).[109,110] BC solutions alone cannot 
form fibers but PG has afforded the BC:PMMA solutions to 
yield fibers that had fiber diameters as low as 690 nm. PG was 
further capable of rapid bandage generation with exceptionally 
high yields. The mat produced resembled bandages that could 
be used directly, requiring no further modification.
5. Future Perspectives
Herein, an extensive number of applications for PG and its 
sister technologies have been showcased. The possibilities that 
this exciting fiber-processing method offer are by no means 
limited to these examples and due to the modular and facile 
nature of this system; we are confident that further modifica-
tions and uses for polymers produced with this technique will 
be revealed.
Unlike electrospinning, PG does not require the use of an 
electric field. So far, electrospinning has had limited scalability 
due to problems with charge interferences in multiple-needle 
setups.[111] The PG setup is capable of spinning 5 mL of pol-
ymer solution in under 15 s whereas, electrospinning will typi-
cally produce fibers at 50 µL min−1 due to limits set by low infu-
sion rates.[112] Infusion gyration is capable of producing fibers 
at 5000 µL min−1, providing a yield of 1.45 kg h−1; further-
more, PG (Mark I) is capable of producing even higher fiber 
yields.[20,34] Therefore, PG allows for high production rates that 
are orders of magnitude higher than electrospinning. Produc-
tion rate coupled with scalable design enables the setup to pro-
duce fibers on an industrially relevant scale, in excess of other 
commercially available fiber production technologies.[112] Even 
compared to commercially available electrospinning techniques 
the production rates are far greater.[26] There are no obstacles 
that prevent its scale-up and the design can be reconfigured by 
changing orifice density and shape, as well as the vessel volume 
to increase yield.
PG is able to spin a large number of polymers with or without 
the requirement of solvents. Melt gyration offers the possibility 
of producing fibers from a large range of polymers by avoiding 
non-economical and/or hazardous solvents. The in situ melting 
of the polymer within the gyration vessel allows for a scalable 
and simple approach to manufacturing small-diameter fibers. 
In the spinning of fibers for biomedical applications, the use 
of certain solvents can lead to the rejection of the final material 
by the Food and Drug Administration. Many of the commonly 
used solvents such as chloroform and dichloromethane are not 
desired in biomedical applications. Melt gyration forms fibers 
free from harsh solvents and thus eliminates further concern to 
health and safety.
Collection of the emerging fibers in the form of a drying pol-
ymer jet is crucial to the morphology of the final fiber product. 
By incorporating different collection techniques, fibers can be 
produced with varying morphologies. If highly aligned fibers 
are desired, then a collector that mimics the rotation of the 
vessel can be created to gather aligned fibers. Stationary and 
dynamic collectors permit the almost-limitless modification of 
fiber morphology to suit various biomedical applications.
The rotational speed of the gyration vessel can determine 
fiber diameter and length. By incorporating updated and modi-
fied designs, the rotational speed can be increased to result 
in the manufacture of thinner diameter fibers with a higher 
production rate. The internal volume of the rotating vessel can 
Macromol. Mater. Eng. 2018, 1800218
Figure 6. Polycaprolactone fibers produced via pressurized gyration, 
demonstrated as a) a patch and b) a wearable bandage.
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be scaled accordingly to increase production rate and fiber con-
tinuity. Orifice count can be increased or decreased to control 
the fiber production rate. Control of orifice diameter and shape 
permits the highly customizable fabrication of fiber products 
with varying morphology and properties. A reduction in ori-
fice diameter can furthermore lead to the formation of smaller 
diameter fibers. Computational 3D modeling can be incorpo-
rated to test the effects of varying vessel dimensions and mate-
rials on the production and scalability of micro- and below 
fibers. Solution properties, such as viscosity and polymer melt 
molecular weight, are also known to have a marked effect.
The creation of core–sheath polymer fibers generated using 
a novel PG process is in progress. The newly designed spin-
neret consists of inner and outer vessels which can accommo-
date two different polymer solutions to generate core–sheath 
structures. This design is also useful for the formation of novel 
structures and encapsulation of other constituents such as 
drugs, nanoparticles, and bioactive agents. In this core–sheath 
polymer fiber manufacturing research, we show that the new 
technology could be used to process different polymer solutions 
and to successfully encapsulate nanoparticles. Future iterations 
of this technology bring great promise in the advancement of 
fiber technologies and their applications.
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